Want to see HEWA full AI Analyst Report?
HEWA Stock Chart & Stats
$0.12
<$0.01(7.37%)
At close: 4:00 PM EDT
$0.12
<$0.01(7.37%)
Day’s Range― - ―
52-Week Range$0.06 - $0.18
Previous CloseN/A
Volume5.00K
Average Volume (3M)18.22K
Market Cap
$5.66M
Enterprise Value$9.88M
Total Cash (Recent Filing)$1.07M
Total Debt (Recent Filing)$3.52M
Price to Earnings (P/E)―
Beta-0.34
Next Earnings
Nov 18, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.02
Shares Outstanding57,190,910
10 Day Avg. Volume30,146
30 Day Avg. Volume18,220
Financial Highlights & Ratios
PEG Ratio0.89
Price to Book (P/B)-1.88
Price to Sales (P/S)0.13
P/FCF Ratio5.83
Enterprise Value/Market Cap1.75
Enterprise Value/Revenue0.32
Enterprise Value/Gross Profit0.70
Enterprise Value/Ebitda-33.83
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Online Pharmacy PlatformThe online pharmacy model gives HealthWarehouse a defined channel for reaching consumers with prescription and over-the-counter products. Its established platform and permitted fulfillment model provide a foundation for serving recurring healthcare demand over the medium term.
Prior Revenue ExpansionThe earlier period of strong revenue expansion indicates the business has demonstrated an ability to grow sales when operating conditions support it. That history provides a foundation for recovery potential, even though the latest TTM period materially reversed the trend.
Improved Gross MarginImproved gross margin suggests the economics of products sold strengthened on a per-revenue basis in the latest period. If maintained, that improvement could help the company convert future sales growth into better operating results, although profitability has not yet stabilized.
Bears Say
Sharp Revenue ContractionThe sharp TTM revenue decline shows that recent demand or sales execution has weakened after earlier growth. A smaller revenue base reduces operating leverage and makes it harder to absorb fixed costs, sustain investment, or return to consistent profitability over the next several quarters.
Return To Operating LossesThe return to operating and net losses demonstrates that profitability remains inconsistent rather than durable. Without sustained earnings, HealthWarehouse has less internally generated capacity to fund operations, strengthen its balance sheet, or invest in growth initiatives.
Negative Equity And Fragile Capital StructurePersistently negative equity materially reduces financial flexibility and leaves the company with a fragile capital structure. Even with moderate absolute debt, leverage is elevated relative to the equity base, increasing refinancing pressure and limiting resilience during weaker operating periods.
HEWA FAQ
What was HealthWarehouse.com Inc’s price range in the past 12 months?
HealthWarehouse.com Inc lowest stock price was $0.06 and its highest was $0.18 in the past 12 months.
What is HealthWarehouse.com Inc’s market cap?
HealthWarehouse.com Inc’s market cap is $5.66M.
When is HealthWarehouse.com Inc’s upcoming earnings report date?
HealthWarehouse.com Inc’s upcoming earnings report date is Nov 18, 2026 which is in 22 days.
How were HealthWarehouse.com Inc’s earnings last quarter?
HealthWarehouse.com Inc released its earnings results on Aug 13, 2026. The company reported -$0.009 earnings per share for the quarter.
Is HealthWarehouse.com Inc overvalued?
According to Wall Street analysts HealthWarehouse.com Inc’s price is currently Overvalued.
Does HealthWarehouse.com Inc pay dividends?
HealthWarehouse.com Inc does not currently pay dividends.
What is HealthWarehouse.com Inc’s EPS estimate?
HealthWarehouse.com Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does HealthWarehouse.com Inc have?
HealthWarehouse.com Inc has 57,190,910 shares outstanding.
What happened to HealthWarehouse.com Inc’s price movement after its last earnings report?
HealthWarehouse.com Inc reported an EPS of -$0.009 in its last earnings report. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of HealthWarehouse.com Inc?
Currently, no hedge funds are holding shares in HEWA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
HealthWarehouse.com Inc
HealthWarehouse.com, Inc. functions as a digital and direct-mail pharmaceutical service. Its offerings encompass a broad spectrum of pharmaceutical items, including generic and brand-name prescription drugs, specialized medications for pets, and a variety of over-the-counter remedies and goods. The company serves customers across all 50 U.S. states and the District of Columbia, specifically targeting the market for prescription drugs paid for directly by consumers. Sales are conducted directly to individual consumers via its online platform. Its corporate headquarters are situated in Florence, Kentucky.
Technical Analysis
Petmed Express
―
ENDRA Life Sciences
―
LifeMD
―
Pasithea Therapeutics Corp
―
Heart Test Laboratories, Inc.
―
Ownership Overview
―
Insiders
―
Mutual Funds
0.02% Other Institutional Investors
99.98% Public Companies and
Individual Investors